E2F-1 regulates expression of FOXO1 and FOXO3a

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1769, Issue 4, 2007, Pages 244-252

  Nowak, Katrin ^a   Killmer, Katrin ^a   Gessner, Christine ^a   Lutz, Werner ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

E2F; FOXO; Neuroblastoma; Neuronal apoptosis; NGF; PC12

Indexed keywords

4 HYDROXYTAMOXIFEN; CYCLOHEXIMIDE; HYBRID PROTEIN; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXO;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING SITE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT;

ANIMALS; APOPTOSIS; E2F1 TRANSCRIPTION FACTOR; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; NERVE TISSUE PROTEINS; NEURONS; PC12 CELLS; PROMOTER REGIONS (GENETICS); RATS;

EID: 34247898772     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbaexp.2007.04.001     Document Type: Article

References (63)

1. Trimarchi J.M., and Lees J.A. Sibling rivalry in the E2F family. Nat. Rev., Mol. Cell Biol. 3 (2002) 11-20
2. Bracken A.P., Ciro M., Cocito A., and Helin K. E2F target genes: unraveling the biology. Trends Biochem. Sci. 29 (2004) 409-417
3. Narita M., Nunez S., Heard E., Lin A.W., Hearn S.A., Spector D.L., Hannon G.J., and Lowe S.W. Rb-Mediated Heterochromatin Formation and Silencing of E2F Target Genes during Cellular Senescence. Cell 113 (2003) 703-716
4. Rowland B.D., Denissov S.G., Douma S., Stunnenberg H.G., Bernards R., and Peeper D.S. E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest. Cancer Cell 2 (2002) 55-65
5. Lazzerini Denchi E., Attwooll C., Pasini D., and Helin K. Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland. Mol. Cell. Biol. 25 (2005) 2660-2672
6. Fajas L., Landsberg R.L., Huss-Garcia Y., Sardet C., Lees J.A., and Auwerx J. E2Fs regulate adipocyte differentiation. Dev. Cell 3 (2002) 39-49
7. Strieder V., and Lutz W. E2F proteins regulate MYCN expression in neuroblastomas. J. Biol. Chem. 278 (2003) 2983-2989
8. Kramps C., Strieder V., Sapetschnig A., Suske G., and Lutz W. E2F and Sp1/Sp3 Synergize but are not sufficient to activate the MYCN gene in neuroblastomas. J. Biol. Chem. 279 (2004) 5110-5117
9. Baudino T.A., Maclean K.H., Brennan J., Parganas E., Yang C., Aslanian A., Lees J.A., Sherr C.J., Roussel M.F., and Cleveland J.L. Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss. Mol. Cell 11 (2003) 905-914
10. Rounbehler R.J., Rogers P.M., Conti C.J., and Johnson D.G. Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model. Cancer Res. 62 (2002) 3276-3281
11. Xiao A., Wu H., Pandolfi P.P., Louis D.N., and Van Dyke T. Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation. Cancer Cell 1 (2002) 157-168
12. Lu X., Magrane G., Yin C., Louis D.N., Gray J., and Van Dyke T. Selective inactivation of p53 facilitates mouse epithelial tumor progression without chromosomal instability. Mol. Cell. Biol. 21 (2001) 6017-6030
13. Giovanni A., Keramaris E., Morris E.J., Hou S.T., O'Hare M., Dyson N., Robertson G.S., Slack R.S., and Park D.S. E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3. J. Biol. Chem. 275 (2000) 11553-11560
14. Liu D.X., and Greene L.A. Regulation of neuronal survival and death by E2F-dependent gene repression and derepression. Neuron 32 (2001) 425-438
15. Liu D.X., Nath N., Chellappan S.P., and Greene L.A. Regulation of neuron survival and death by p130 and associated chromatin modifiers. Genes Dev. 19 (2005) 719-732
16. Liu D.X., Biswas S.C., and Greene L.A. B-myb and C-myb play required roles in neuronal apoptosis evoked by nerve growth factor deprivation and DNA damage. J. Neurosci. 24 (2004) 8720-8725
17. Biswas S.C., Liu D.X., and Greene L.A. Bim is a direct target of a neuronal E2F-dependent apoptotic pathway. J. Neurosci. 25 (2005) 8349-8358
18. Greene L.A., Biswas S.C., and Liu D.X. Cell cycle molecules and vertebrate neuron death: E2F at the hub. Cell Death Differ. 11 (2004) 49-60
19. O'Hare M.J., Hou S.T., Morris E.J., Cregan S.P., Xu Q., Slack R.S., and Park D.S. Induction and modulation of cerebellar granule neuron death by E2F-1. J. Biol. Chem. 275 (2000) 25358-25364
20. Persengiev S.P., Kondova I.I., and Kilpatrick D.L. E2F4 actively promotes the initiation and maintenance of nerve growth factor-induced cell differentiation. Mol. Cell. Biol. 19 (1999) 6048-6056
21. Greer E.L., and Brunet A. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24 (2005) 7410-7425
22. Accili D., and Arden K.C. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117 (2004) 421-426
23. Burgering B.M., and Kops G.J. Cell cycle and death control: long live Forkheads. Trends Biochem. Sci. 27 (2002) 352-360
24. Hosaka T., Biggs III W.H., Tieu D., Boyer A.D., Varki N.M., Cavenee W.K., and Arden K.C. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 2975-2980
25. Lehtinen M.K., Yuan Z., Boag P.R., Yang Y., Villen J., Becker E.B., DiBacco S., de la Iglesia N., Gygi S., Blackwell T.K., and Bonni A. A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 125 (2006) 987-1001
26. Bouchard C., Marquardt J., Bras A., Medema R.H., and Eilers M. Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins. EMBO J. 23 (2004) 2830-2840
27. Galili N., Davis R.J., Fredericks W.J., Mukhopadhyay S., Rauscher III F.J., Emanuel B.S., Rovera G., and Barr F.G. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat. Genet. 5 (1993) 230-235
28. Li P., Lee H., Guo S., Unterman T.G., Jenster G., and Bai W. AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR. Mol. Cell. Biol. 23 (2003) 104-118
29. Gilley J., Coffer P.J., and Ham J. FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J. Cell Biol. 162 (2003) 613-622
30. Dijkers P.F., Medema R.H., Lammers J.W., Koenderman L., and Coffer P.J. Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr. Biol. 10 (2000) 1201-1204
31. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., and Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96 (1999) 857-868
32. Zheng W.H., Kar S., and Quirion R. FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling. J. Neurochem. 80 (2002) 1049-1061
33. Hallstrom T.C., and Nevins J.R. Specificity in the activation and control of transcription factor E2F-dependent apoptosis. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 10848-10853
34. Yamamura Y., Lee W.L., Inoue K., Ida H., and Ito Y. RUNX3 cooperates with FoxO3a to induce apoptosis in gastric cancer cells. J. Biol. Chem. 281 (2006) 5267-5276
35. Seoane J., Le H.V., Shen L., Anderson S.A., and Massague J. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117 (2004) 211-223
36. Lutz W., Stohr M., Schurmann J., Wenzel A., Lohr A., and Schwab M. Conditional expression of N-myc in human neuroblastoma cells increases expression of alpha-prothymosin and ornithine decarboxylase and accelerates progression into S-phase early after mitogenic stimulation of quiescent cells. Oncogene 13 (1996) 803-812
37. Nakamura N., Ramaswamy S., Vazquez F., Signoretti S., Loda M., and Sellers W.R. Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol. Cell. Biol. 20 (2000) 8969-8982
38. Vigo E., Muller H., Prosperini E., Hateboer G., Cartwright P., Moroni M.C., and Helin K. CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol. Cell. Biol. 19 (1999) 6379-6395
39. Nowak K., Kerl K., Fehr D., Kramps C., Gessner C., Killmer K., Samans B., Berwanger B., Christiansen H., and Lutz W. BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas. Nucleic Acids Res. 34 (2006) 1745-1754
40. Taubert S., Gorrini C., Frank S.R., Parisi T., Fuchs M., Chan H.M., Livingston D.M., and Amati B. E2F-dependent histone acetylation and recruitment of the Tip60 acetyltransferase complex to chromatin in late G1. Mol. Cell. Biol. 24 (2004) 4546-4556
41. Pittman R.N., Wang S., DiBenedetto A.J., and Mills J.C. A system for characterizing cellular and molecular events in programmed neuronal cell death. J. Neurosci. 13 (1993) 3669-3680
42. Munoz J., Lazcoz P., Inda M.M., Nistal M., Pestana A., Encio I.J., and Castresana J.S. Homozygous deletion and expression of PTEN and DMBT1 in human primary neuroblastoma and cell lines. Int. J. Cancer 109 (2004) 673-679
43. Dijkers P.F., Birkenkamp K.U., Lam E.W., Thomas N.S., Lammers J.W., Koenderman L., and Coffer P.J. FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity. J. Cell Biol. 156 (2002) 531-542
44. Kops G.J., Medema R.H., Glassford J., Essers M.A., Dijkers P.F., Coffer P.J., Lam E.W., and Burgering B.M. Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol. Cell Biol. 22 (2002) 2025-2036
45. Medema R.H., Kops G.J., Bos J.L., and Burgering B.M. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404 (2000) 782-787
46. van der Heide L.P., and Smidt M.P. Regulation of FoxO activity by CBP/p300-mediated acetylation. Trends Biochem. Sci. 30 (2005) 81-86
47. Hu M.C., Lee D.F., Xia W., Golfman L.S., Ou-Yang F., Yang J.Y., Zou Y., Bao S., Hanada N., Saso H., Kobayashi R., and Hung M.C. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117 (2004) 225-237
48. Motta M.C., Divecha N., Lemieux M., Kamel C., Chen D., Gu W., Bultsma Y., McBurney M., and Guarente L. Mammalian SIRT1 represses forkhead transcription factors. Cell 116 (2004) 551-563
49. Brunet A., Sweeney L.B., Sturgill J.F., Chua K.F., Greer P.L., Lin Y., Tran H., Ross S.E., Mostoslavsky R., Cohen H.Y., Hu L.S., Cheng H.L., Jedrychowski M.P., Gygi S.P., Sinclair D.A., Alt F.W., and Greenberg M.E. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303 (2004) 2011-2015
50. van der Horst A., de Vries-Smits A.M., Brenkman A.B., van Triest M.H., van den Broek N., Colland F., Maurice M.M., and Burgering B.M. FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP. Nat. Cell Biol. 8 (2006) 1064-1073
51. Dimova D.K., Stevaux O., Frolov M.V., and Dyson N.J. Cell cycle-dependent and cell cycle-independent control of transcription by the Drosophila E2F/RB pathway. Genes Dev. 17 (2003) 2308-2320
52. Iwanaga R., Komori H., Ishida S., Okamura N., Nakayama K., Nakayama K.I., and Ohtani K. Identification of novel E2F1 target genes regulated in cell cycle-dependent and independent manners. Oncogene 25 (2006) 1786-1798
53. Wang C., Chen L., Hou X., Li Z., Kabra N., Ma Y., Nemoto S., Finkel T., Gu W., Cress W.D., and Chen J. Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat. Cell Biol. 8 (2006) 1025-1031
54. Suzuki A., and Hemmati-Brivanlou A. Xenopus embryonic E2F is required for the formation of ventral and posterior cell fates during early embryogenesis. Mol. Cell 5 (2000) 217-229
55. Vyas S., Juin P., Hancock D., Suzuki Y., Takahashi R., Triller A., and Evan G. Differentiation-dependent sensitivity to apoptogenic factors in PC12 cells. J. Biol. Chem. 279 (2004) 30983-30993
56. Aslanian A., Iaquinta P.J., Verona R., and Lees J.A. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics. Genes Dev. 18 (2004) 1413-1422
57. Foijer F., Wolthuis R.M., Doodeman V., Medema R.H., and te Riele H. Mitogen requirement for cell cycle progression in the absence of pocket protein activity. Cancer Cell 8 (2005) 455-466
58. Obexer P., Geiger K., Ambros P.F., Meister B., and Ausserlechner M.J. FKHRL1-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells. Cell Death Differ. 14 (2007) 534-547
59. Nemoto S., Fergusson M.M., and Finkel T. Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science 306 (2004) 2105-2108
60. Huang H., Regan K.M., Lou Z., Chen J., and Tindall D.J. CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage. Science 314 (2006) 294-297
61. Chaussepied M., and Ginsberg D. Transcriptional regulation of AKT activation by E2F. Mol. Cell 16 (2004) 831-837
62. Davis R.J., Bennicelli J.L., Macina R.A., Nycum L.M., Biegel J.A., and Barr F.G. Structural characterization of the FKHR gene and its rearrangement in alveolar rhabdomyosarcoma. Hum. Mol. Genet. 4 (1995) 2355-2362
63. Yamashita R., Suzuki Y., Wakaguri H., Tsuritani K., Nakai K., and Sugano S. DBTSS: DataBase of Human Transcription Start Sites, progress report 2006. Nucleic Acids Res. 34 (2006) D86-D89